A fourth ex-US Coast Guard cutter has been transferred to the Sri Lanka Navy, US Ambassador to Sri Lanka, Julie Chung, said yesterday. Posting on X, Chung said the vessel will embolden Sri Lanka’s ...

The US Embassy in Colombo has recently congratulated two Sri Lankan navy officers for completing training programmes in the United States underlining deepening military cooperation between the two ...

The latest price target for Silence Therapeutics (NASDAQ:SLN) was reported by HC Wainwright & Co. on September 16, 2025. The analyst firm set a price target for $75.00 expecting SLN to rise to within ...

Sentinel lymph node (SLN) biopsy for early cervical cancer achieved non-inferiority versus pelvic lymphadenectomy, according to results of a large randomized study from China. Patients assigned to SLN ...

Goldman Sachs initiated Silence Therapeutics (NASDAQ:SLN) with a Sell rating and a $6 price target on Tuesday, arguing that with only about $173M of cash and equivalents at the end of Q3 2024, the U.K ...

With all this snow across New York State to start 2025 off with, someone turned those lemons into lemonade creating a record breaking tall snowman. Coming in at 23 feet, 10 inches, meet the St.

Shares of Silence Therapeutics SLN plunged 36.8% on Tuesday despite reporting positive end-of-treatment data from a mid-stage study of lead candidate, zerlasiran, to treat atherosclerotic ...

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Silence Therapeutics (SLN – Research Report) today and set a price target of $49.00. The company’s shares closed last Friday at $17.99.

A startup has outfitted Milbrae pickleball courts with sound proof barriers to mitigate noise complaints from home owners. © 2025 American City Business Journals ...

BMO Capital Markets said it views BioMarin Pharmaceutical (NASDAQ:BMRN), Legend Biotech (NASDAQ:LEGN) and Silence Therapeutics (NASDAQ:SLN) as attractive takeover targets following Eli Lilly’s (LLY) ...

Officially, the NBA's logo is blank. It is an anonymous, faceless player dribbling a ball against a red and white background. That's the NBA's story and it's sticking to it. Unofficially, however, the ...

A phase 2 study to determine the pathological (path) response to neoadjuvant nivolumab (nivo) and relatlimab (rela) in stage I to III resectable Merkel cell carcinoma (Neo-MCC). This is an ASCO ...